Beam Therapeutics Inc. (BEAM)

Typically moves ±6.18% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-04 APPROXIMATE

Across 27 earnings reports since Mar 30, 2020, Beam Therapeutics Inc. (BEAM) has a clear post-earnings pattern. It moves ±6.18% on average after reporting and finishes higher 40.7% of the time. Its largest post-earnings gain was +25.89% (Feb 27, 2024) and its largest decline was -19.32% (May 06, 2025). The next earnings report is predicted for 2026-11-04 (approximate).

Earnings reactions

How BEAM moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.18%

Positive %

40.7%

Negative %

59.3%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 04, 2026	☀ PRE	+9.53%	open_in_new
May 07, 2026	☀ PRE	-2.75%	open_in_new
Feb 24, 2026	☀ PRE	+13.98%	open_in_new
Nov 04, 2025	☀ PRE	-6.23%	open_in_new
Aug 05, 2025	☀ PRE	-2.2%	open_in_new
May 06, 2025	☀ PRE	-19.32%	open_in_new
Feb 25, 2025	☀ PRE	-3.09%	open_in_new
Nov 05, 2024	☀ PRE	-1.77%	open_in_new
Aug 06, 2024	☀ PRE	-0.35%	open_in_new
May 07, 2024	☀ PRE	-1.1%	open_in_new
Feb 27, 2024	☀ PRE	+25.89%	open_in_new
Nov 08, 2023	☀ PRE	-8.36%	open_in_new
Aug 08, 2023	☀ PRE	+2.78%	open_in_new
May 10, 2023	☀ PRE	+3.88%	open_in_new
Feb 28, 2023	☀ PRE	+3.21%	open_in_new
Nov 07, 2022	☀ PRE	-11.43%	open_in_new
Aug 09, 2022	☀ PRE	-4.29%	open_in_new
May 09, 2022	☀ PRE	-6.7%	open_in_new
Feb 28, 2022	☀ PRE	+4.82%	open_in_new
Nov 08, 2021	☀ PRE	+10.64%	open_in_new
Aug 10, 2021	☀ PRE	-2.51%	open_in_new
May 11, 2021	☀ PRE	+3.24%	open_in_new
Mar 15, 2021	☀ PRE	-3.66%	open_in_new
Nov 10, 2020	☀ PRE	+2.03%	open_in_new
Aug 12, 2020	☀ PRE	-5.67%	open_in_new
May 12, 2020	☽ POST	+7.27%	open_in_new
Mar 30, 2020	☀ PRE	-0.28%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.18%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 29 →

Funds holding

$771369735

Total value held

Buying

24 added · 2 reduced

Blackrock, Inc.

$308795642 +6.01%

State Street Corp

$199986827 +2.24%

Morgan Stanley

$66957279 +200.95%

Goldman Sachs Group Inc

$44961225 +30.26%

Northern Trust Corp

$32037069 +13.07%

SEC Filing Types

description SCHEDULE 13G/A

17 chevron_right

description SC 13G

13 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260813	open_in_new SEC.gov
10-Q	20260804	open_in_new SEC.gov
8-K	20260804	open_in_new SEC.gov
4	20260729	open_in_new SEC.gov
144	20260727	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260701	open_in_new SEC.gov
144	20260630	open_in_new SEC.gov
144	20260629	open_in_new SEC.gov

Frequently asked about BEAM earnings

When does Beam Therapeutics Inc. report earnings next? expand_more

Beam Therapeutics Inc. (BEAM)'s next earnings date is approximate for 2026-11-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does BEAM stock move after earnings? expand_more

Over 27 reports, BEAM has moved an average of ±6.18% the session after earnings, closing higher 40.7% of the time.

What was BEAM's biggest post-earnings move? expand_more

BEAM's largest post-earnings gain on record was +25.89% on Feb 27, 2024, and its largest decline was -19.32% on May 06, 2025.

Where can I find Beam Therapeutics Inc.'s SEC filings? expand_more

All of Beam Therapeutics Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.